Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H34O11 |
| Molecular Weight | 534.5523 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C[C@H]2COC(=O)[C@@H]2CC3=CC(OC)=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C3)C=C1OC
InChI
InChIKey=XOJVHLIYNSOZOO-SWOBOCGESA-N
InChI=1S/C27H34O11/c1-33-18-6-4-14(10-20(18)34-2)8-16-13-36-26(32)17(16)9-15-5-7-19(21(11-15)35-3)37-27-25(31)24(30)23(29)22(12-28)38-27/h4-7,10-11,16-17,22-25,27-31H,8-9,12-13H2,1-3H3/t16-,17+,22+,23+,24-,25+,27+/m0/s1
| Molecular Formula | C27H34O11 |
| Molecular Weight | 534.5523 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23691032Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18288407
https://www.ncbi.nlm.nih.gov/pubmed/15042601
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23691032
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18288407
https://www.ncbi.nlm.nih.gov/pubmed/15042601
Arctiin, isolated from Forsythia suspensa has been reported to have anti-inflammatory, anti-oxidant, antibacterial, and antiviral effects in vitro. It has been found to act as agonist of the adiponectin receptor 1. Has a potential role in the treatment of obesity. Arctiin has being shown to have anticancer effects in animal research.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL6161 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27145339 |
16.0 µM [Ki] | ||
Target ID: GO:0060612 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25489405 |
|||
Target ID: GO:0001935 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24163109 |
|||
Target ID: CHEMBL3392946 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23691032 |
1.2 µM [IC50] | ||
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21733191 |
|||
Target ID: CHEMBL3610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18288407 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bioactivity-guided isolation of antiproliferative compounds from Centaurea arenaria. | 2010-11 |
|
| Determination of the major constituents in fruit of Arctium lappa L. by matrix solid-phase dispersion extraction coupled with HPLC separation and fluorescence detection. | 2010-10-15 |
|
| On-line coupling of counter-current chromatography and macroporous resin chromatography for continuous isolation of arctiin from the fruit of Arctium lappa L. | 2010-08-13 |
|
| Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria. | 2010-04-16 |
|
| Mass fragmentation study of the trimethylsilyl derivatives of arctiin, matairesinoside, arctigenin, phylligenin, matairesinol, pinoresinol and methylarctigenin: their gas and liquid chromatographic analysis in plant extracts. | 2010-03-05 |
|
| Metabolic profile of the bioactive compounds of burdock (Arctium lappa) seeds, roots and leaves. | 2010-01-20 |
|
| Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling. | 2010-01-04 |
|
| Dibenzylbutyrolactone lignans from Forsythia koreana fruits attenuate lipopolysaccharide-induced inducible nitric oxide synthetase and cyclooxygenase-2 expressions through activation of nuclear factor-κb and mitogen-activated protein kinase in RAW264.7 cells. | 2010 |
|
| Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. | 2010 |
|
| Bioassay-guided isolation and identification of active compounds from Fructus Arctii against Dactylogyrus intermedius (Monogenea) in goldfish (Carassius auratus). | 2009-12 |
|
| Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats. | 2009-11 |
|
| Further studies on a human intestinal bacterium Ruminococcus sp. END-1 for transformation of plant lignans to mammalian lignans. | 2009-08-26 |
|
| Natural Arctium lappa fruit extract improves the clinical signs of aging skin. | 2008-12 |
|
| In vitro and in vivo anti-allergic effects of Arctium lappa L. | 2008-11 |
|
| Treatment with SI000413, a new herbal formula, ameliorates murine collagen-induced arthritis. | 2008-07 |
|
| Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression. | 2008-03 |
|
| Microemulsion electrokinetic chromatography for the separation of arctiin and arctigenin in Fructus Arctii and its herbal preparations. | 2007-12-01 |
|
| The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme. | 2007-12 |
|
| Inhibitory effect of nordihydroguaiaretic acid, a plant lignan, on Helicobacter pylori-associated gastric carcinogenesis in Mongolian gerbils. | 2007-11 |
|
| Isolation and characterization of a human intestinal bacterium, Eubacterium sp. ARC-2, capable of demethylating arctigenin, in the essential metabolic process to enterolactone. | 2007-05 |
|
| A new lignan glycoside from the stem bark of Styrax japonica S. et Z. | 2007-04 |
|
| Antiviral activity of berberine and related compounds against human cytomegalovirus. | 2007-03-15 |
|
| [Relative adscriptions of components in the effective fractions of Yinqiao decoction and its composing individual herbs]. | 2007-02 |
|
| In-vitro and in-vivo anti-inflammatory action of the ethanol extract of Trachelospermi caulis. | 2007-01 |
|
| Lack of a significant effect of arctiin on development of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats. | 2007 |
|
| Americanin, a bioactive dibenzylbutyrolactone lignan, from the seeds of Centaurea americana. | 2006-11 |
|
| [Study on condition for extraction of arctiin from fruits of Arctium lappa using supercritical fluid extraction]. | 2006-08 |
|
| Determination of phillyrin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies. | 2006-05-03 |
|
| Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells. | 2006 |
|
| A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and glycyrrhizin in a Chinese proprietary medicine. | 2005-09-15 |
|
| [Dyuamical studies on metabolic chemistry of lignans from seeds of Arctium lappa]. | 2005-08 |
|
| Lack of significant modifying effect of arctiin on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. | 2005-05-26 |
|
| Isolation and identification of arctiin and arctigenin in leaves of burdock (Arctium lappa L.) by polyamide column chromatography in combination with HPLC-ESI/MS. | 2005-05-11 |
|
| Application of preparative high-speed counter-current chromatography for separation and purification of arctiin from Fructus Arctii. | 2005-01-21 |
|
| The content of lignan glycosides in Forsythia flowers and leaves. | 2004-12-04 |
|
| Isolation and identification of biologically active compounds from Forsythia viridissima flowers. | 2004-10-16 |
|
| [Clinical observation on treatment of diabetic nephropathy with compound fructus arctii mixture]. | 2004-07 |
|
| Modulation of anti-adhesion molecule MUC-1 is associated with arctiin-induced growth inhibition in PC-3 cells. | 2004-05-15 |
|
| Effects of forsythia fruit extracts and lignan on lipid metabolism. | 2004 |
|
| Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats. | 2003-10-28 |
|
| Simultaneous determination of chlorogenic acid, forsythin and arctiin in Chinese traditional medicines preparation by reversed phase-HPLC. | 2003-04 |
|
| Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria. | 2003-04 |
|
| [Isolation and elucidation of chemical constituents with antiviral action from yinqiaosan on influenza virus]. | 2003-01 |
|
| Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. | 2002 |
|
| Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera. | 2001-07 |
|
| Effects of the lignan, arctiin, on 17-beta ethinyl estradiol promotion of preneoplastic liver cell foci development in rats. | 1998-06-06 |
|
| Differential in vitro anti-HIV activity of natural lignans. | 1990-11-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23147865
STZ-induced diabetic rats were treated with arctiin at the dosage of 60 or 40 mg/kg/day via intraperitoneal injection for 8 weeks.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25489405
Arctiin treatment of 3T3-L1 pre-adipocytes markedly decreased adipogenesis in a dose-dependent manner (12.5 to 100 uM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:05:22 GMT 2025
by
admin
on
Mon Mar 31 20:05:22 GMT 2025
|
| Record UNII |
TM5RQ949K7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1145
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100528
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
DTXSID20942519
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
C93250
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
C077992
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
TM5RQ949K7
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
315527
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
ARCTIIN
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY | |||
|
20362-31-6
Created by
admin on Mon Mar 31 20:05:22 GMT 2025 , Edited by admin on Mon Mar 31 20:05:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
TARGET -> AGONIST |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
36% Cell growth rate of M1 cells at 50 uM of compound vs control
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|